<<Prev Rule

Texas Administrative Code

Next Rule>>
TITLE 28INSURANCE
PART 1TEXAS DEPARTMENT OF INSURANCE
CHAPTER 21TRADE PRACTICES
SUBCHAPTER KKHEALTH CARE REIMBURSEMENT RATE INFORMATION
RULE §21.4507Data Required

      (xxii) MRI both breasts;

      (xxiii) MRI pelvis;

      (xxiv) mammogram, analog;

      (xxv) mammogram with CAD; and

      (xxvi) mammogram, digital.

  (5) Pathology services. Data on pathology services must be reported only for professional claims for which the place of service is an independent lab.

    (A) Data must be reported at the claim-line level and averaged to reflect the cost per unit of service.

    (B) Data must be reported for the following pathology services, using the medical billing codes consistent with §21.4505(b) of this title:

      (i) organ or disease panels;

      (ii) evocative suppression testing;

      (iii) urinalysis;

      (iv) chemistry;

      (v) hematology-coagulation;

      (vi) immunology;

      (vii) microbiology;

      (viii) anatomic pathology;

      (ix) screening cytopathology; and

      (x) complete blood count.

  (6) Office visits. Data on office visits must be reported only for professional claims for which the place of service is an office or rural health clinic.

    (A) For data elements listed in subparagraph (B) of this paragraph, data must be reported at the claim-line level and averaged to reflect the cost per unit of service.

    (B) Data must be reported for the following types of office visits, using the medical billing codes consistent with §21.4505(b) of this title:

      (i) office or other outpatient visit with a new patient, by time or complexity;

      (ii) office or other outpatient visit with an established patient, by time or complexity;

      (iii) office consultation, by time or complexity;

      (iv) preventive medicine evaluation and management, new patient, by age group;

      (v) preventive medicine evaluation and management, established patient, by age group;

      (vi) annual gynecological exam, new patient;

      (vii) annual gynecological exam, established patient;

      (viii) screening pelvic and breast exam;

      (ix) screening pap smear; and

      (x) cytopathology for pap smear.

    (C) Data must be reported for well-woman exams so that all costs associated with a claim are reported with respect to the medical billing consistent with §21.4505(b) of this title.

(d) In reporting data required under this section, issuers must:

  (1) report data elements according to medical billing codes specified by §21.4505(b) of this title;

  (2) separately report data for insurance and HMO and exclude any HMO claims paid through a capitation agreement;

  (3) separately report data for in-network and out-of-network claims; and

  (4) filter claims data to include only:

    (A) claims incurred during the 12-month reporting period. For the 2015 reporting period, limit data for inpatient procedure claims and outpatient procedure claims to claims incurred before October 1, 2015, or the date on which the issuer transitioned billing systems to use ICD-10 procedure codes;

    (B) claims for which adjudication is final; exclude pending or denied claims;

    (C) claims for which the issuer is the primary plan responsible for payment; exclude claims for which issuer is the secondary plan; and

    (D) claims with an allowed amount greater than zero.


Source Note: The provisions of this §21.4507 adopted to be effective January 9, 2011, 35 TexReg 11868; amended to be effective June 6, 2016, 41 TexReg 4027

Previous Page

Link to Texas Secretary of State Home Page | link to Texas Register home page | link to Texas Administrative Code home page | link to Open Meetings home page